You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
Last month, the foundation, in partnership with the Washington State Department of Health, released seven educational videos about prenatal testing.
Revisions to the reimbursement catalog went into effect July 1, but stakeholders are quarreling about a pre-authorization requirement in court.
Geisinger Health System's MyCode Community Health Initiative has signed up more than 100,000 participants and has returned results to about 100 patients.
Over the last half year, CeGaT lowered turnaround times and prices for its assays, and its lab recently passed CAP inspection.
The decision was made after Geisinger researchers and clinicians presented the health plan with evidence of the clinical utility of exome sequencing.
For many patients, the diagnosis led to a change in medical care or management, averted additional diagnostic tests, and facilitated family planning.
A genetic testing utilization service launched by Stanford in 2015 helped cut the number of inappropriately ordered tests in half and saved about $250,000 during the first year.
The researchers say their technique is most effective when used to replace regions of DNA up to 30 base pairs.
The company's 22q11.2 microdeletion test classified almost 0.5 percent of cases as high risk, among them at least 11 true positives and 50 false positives.
The Saudi Arabian research team analyzed the autozygomes and exomes of 31 families and found a strong candidate variant in 90 percent of them.
NPR reports that researchers have developed chimeric embryos as part of work toward growing human organs in animals for organ transplants.
According to the Washington Post, the Biden Administration is set to make changes to federal restrictions on fetal tissue research.
In Science this week: approach to isolated trace DNA from archaic humans from sediments, and more.
Texas Monthly looks into the DNA Zoo being collected by Baylor College of Medicine researchers.